Difficulty: Intermediate | Prerequisites: Nerve preservation and neuromonitoring notes (Part 1), basic middle ear anatomy, general anaesthesia pharmacology
Tags: middle ear surgery, tympanoplasty, stapedectomy, mastoidectomy, nitrous oxide, N₂O, bloodless field, controlled hypotension, PONV, dexmedetomidine, CRNA, nurse anesthesia, otologic surgery
Middle ear surgery is microsurgery performed in a tiny, enclosed, air-filled space that sits millimetres from the facial nerve, the brain, and the structures of hearing and balance. The anaesthetist must simultaneously keep the surgical field dry (no bleeding), protect nerve monitoring, manage the pressure physics of nitrous oxide in a closed cavity, and prevent the nausea and vomiting that middle ear procedures are notorious for. These four demands pull in different pharmacological directions, and understanding how to balance them is the core skill being tested. This topic builds on the nerve preservation material in Part 1 and adds the remaining three of the "four major concerns."
Middle ear procedures need a bloodless field (head-up tilt, normocapnia, controlled hypotension), careful N₂O management (avoid it in tympanoplasty, or stop it at least 15 minutes before graft placement), and aggressive PONV prophylaxis. Either local or general anaesthesia can be used. Under general anaesthesia, muscle relaxants are withheld after intubation to preserve facial nerve EMG, and emergence must be smooth and cough-free to protect grafts and prostheses.
Tympanic membrane (eardrum)
The thin membrane separating the external ear canal from the middle ear. In simple terms, it is the drum that vibrates when sound hits it.
Oval window
The membrane-covered opening between the middle ear and the inner ear (cochlea). The stapes footplate sits against it, transmitting vibrations inward.
Eustachian tube
The channel connecting the middle ear to the nasopharynx. It normally vents pressure changes. In anaesthetised patients, the tube cannot be actively opened by swallowing or yawning, which is why N₂O-driven pressure builds up.
Ossicles (malleus, incus, stapes)
The three tiny bones of the middle ear that form a chain transmitting sound vibration from the eardrum to the cochlea.
Stylomastoid foramen
The bony opening through which the facial nerve exits the skull. The nerve passes through the middle ear cavity before reaching this point, placing it at risk during any middle ear procedure.
Tympanoplasty
Surgical reconstruction of the tympanic membrane, sometimes including ossicular repair. This is the procedure where N₂O poses the greatest risk, because a newly placed graft can be displaced by pressure changes.
Stapedectomy / ossiculoplasty
Replacement or reconstruction of the stapes bone, typically for otosclerosis. A prosthesis replaces the fixed stapes, and coughing or straining at emergence can dislodge it.
Mastoidectomy
Removal of infected mastoid air cells. Performed in both adults and children.
Cholesteatoma
An abnormal collection of keratinised squamous epithelium in the middle ear, often requiring surgical removal.
Controlled hypotension
A deliberate reduction in blood pressure to minimise surgical bleeding. Target systolic BP is 80 to 90 mm Hg, or a reduction of MAP to 20% of baseline.
PONV (postoperative nausea and vomiting)
Extremely common after middle ear surgery. Multiple contributing factors: vestibular disturbance, opioids, N₂O, and the outpatient nature of these cases (vomiting delays discharge).
EMLA (eutectic mixture of local anaesthetics)
A topical preparation of lidocaine and prilocaine used to reduce pain from local anaesthetic injections at the start of surgery. Think of it as a numbing cream applied before the needle.
Dexmedetomidine
An alpha-2 adrenergic agonist that produces sedation, analgesia and a modest reduction in heart rate and blood pressure, without respiratory depression. Used as an adjunct for controlled hypotension or as a primary sedative with low-dose propofol and midazolam for IV sedation.
LMA (laryngeal mask airway)
A supraglottic airway device. Suitable for many middle ear cases unless extreme neck extension or rotation is required, in which case endotracheal intubation is preferred.
In adults:
Tympanoplasty (reconstruction of the tympanic membrane)
Stapedectomy or ossiculoplasty for otosclerosis
Mastoidectomy (removal of infected mastoid air cells)
Removal of a cholesteatoma
In children:
Tympanoplasty
Mastoidectomy
Myringotomy (covered in Part 3)
Grommet insertion (covered in Part 3)
Cochlear implantation
The middle ear is the air-filled space between the tympanic membrane and the oval window. It connects to the nasopharynx via the eustachian tube and lies close to the temporal lobe, cerebellum, jugular bulb and labyrinth of the inner ear. The three ossicles (malleus, incus, stapes) transmit sound from the eardrum to the cochlea. The facial nerve traverses this cavity before exiting through the stylomastoid foramen, supplying the muscles of facial expression.
This anatomy explains why middle ear surgery carries risks to hearing (ossicles, cochlea), balance (labyrinth), facial movement (CN VII) and, in rare cases, intracranial structures.
Middle ear surgery can use either local or general anaesthesia.
Local anaesthesia with sedation requires a cooperative patient who can remain still under drapes for extended periods.
Main advantages: the ability to test hearing during surgery, and less bleeding.
Pain is a primary problem at the start, when multiple injections of local anaesthetic with epinephrine are given. Topical EMLA may improve comfort.
General anaesthesia is used when patient cooperation is uncertain or when the surgical approach demands it.
Airway: LMA or endotracheal intubation. Intubation is more appropriate if extreme neck extension or rotation is needed.
Muscle relaxants are avoided after intubation (facial nerve EMG monitoring).
A smooth, cough-free emergence is essential to prevent prosthesis displacement after reconstructive surgery.
Most middle ear procedures are outpatient, so rapid recovery, good analgesia and avoidance of nausea/vomiting are priorities.
This is a classic exam topic and one of the four core concerns.
The physics: N₂O is 34 times more soluble than nitrogen in blood. It enters the middle ear cavity more rapidly than nitrogen leaves. If the eustachian tube is obstructed (as it is in an anaesthetised patient who cannot swallow or yawn), pressure in the middle ear rises.
Positive pressure ventilation can compound the problem by forcing air into the middle ear through the eustachian tubes.
The two-phase problem in tympanoplasty:
During surgery (cavity open): The middle ear is open to atmosphere, so pressure does not build up.
Once the tympanic membrane graft is placed: Continued N₂O can displace the graft.
At the end of surgery (N₂O discontinued): The remaining N₂O is rapidly absorbed, creating negative pressure. This can cause graft dislodgement, serous otitis media, disarticulation of the stapes, or impaired hearing.
Management of N₂O:
Some clinicians discontinue N₂O at least 15 minutes before closure of the middle ear.
Because N₂O is only a supplement to general anaesthesia, avoiding it altogether during tympanoplasty is the more reasonable approach.
N₂O also increases PONV, which is already common after this surgery, giving a second reason to avoid it.
A bloodless field is mandatory for middle ear microsurgery. Both physical and pharmacological techniques are used.
Physical techniques:
Head-up tilt of 15 to 20 degrees
Avoidance of venous obstruction and congestion (proper head positioning)
Normocapnia
Controlled hypotension
Controlled hypotension targets:
Ideal systolic BP: 80 to 90 mm Hg
Or a reduction of MAP to 20% of baseline in hypertensive patients
A slightly elevated head position reduces arterial and venous pressures above the heart, but increases the risk of air embolism
Pharmacological agents for controlled hypotension in ENT surgery:
Inhalation anaesthetics (volatile agents)
Beta-adrenoceptor antagonists (labetalol, esmolol)
Alpha-2 adrenergic agonists (dexmedetomidine)
Opioids (remifentanil)
Magnesium sulfate (a more recent addition)
Dexmedetomidine is particularly useful as an adjunct. It provides sedation, analgesia and a modest reduction in heart rate and blood pressure without respiratory depression. It can be used to lower blood pressure during general anaesthesia, or as the primary sedative with supplementary low-dose propofol and midazolam for IV sedation.
Middle ear surgery has one of the highest PONV rates in all of surgery. Contributing factors include vestibular disturbance, opioid use, and N₂O exposure. The combination of physical and pharmacological anti-emetic strategies should be planned from the start of the case, not added as an afterthought.
At completion, the head is lifted and usually wrapped with a bandage. The anaesthetist's goal is to avoid excessive coughing and bucking. Deep extubation (removing the ETT while the patient is still at a sufficient depth of anaesthesia) may be considered provided there are no contraindications.
The controlled hypotension targets (SBP 80 to 90, or MAP to 20% of baseline) are the numbers an anaesthetist actually dials in during a middle ear case. Getting this wrong in either direction matters: too high and the surgeon cannot see, too low and you risk cerebral or renal hypoperfusion. The head-up tilt that helps bleeding control simultaneously raises air embolism risk, so vigilance for that complication is part of the real workflow.
Students often assume N₂O must be avoided in all middle ear surgery without exception. It must be avoided (or stopped early) in tympanoplasty and similar graft-based procedures, but in myringotomy (see Part 3) the effects are not relevant because the procedure creates an open vent in the tympanic membrane.
The two-phase problem with N₂O is commonly misunderstood. The danger is not just positive pressure during surgery; the negative pressure on washout (when N₂O is discontinued) can be equally or more damaging.
Students may think controlled hypotension means "the lower the better." There is a defined target range (SBP 80 to 90, MAP to 20% of baseline), and going below it introduces its own risks.
PONV after middle ear surgery is sometimes treated as a minor nuisance. In an outpatient setting, it delays discharge and is a major source of patient dissatisfaction. Exam questions expect aggressive prophylaxis.
⚠️ The N₂O solubility ratio (34 times more soluble than nitrogen) and its mechanism of action in a closed air space is a classic exam question, often phrased as a clinical scenario.
⚠️ The two-phase problem (positive pressure during surgery, negative pressure on washout) appears frequently. Know both phases and their consequences.
⚠️ Controlled hypotension targets (SBP 80 to 90 mm Hg, or MAP to 20% of baseline) are testable numbers.
⚠️ The advantages of dexmedetomidine (sedation, analgesia, modest HR/BP reduction, no respiratory depression) are commonly tested in pharmacology sections.
⚠️ The importance of cough-free emergence and the rationale for deep extubation come up in scenario-based questions about postoperative graft or prosthesis displacement.
True or false: N₂O should be avoided in all middle ear procedures without exception.
Fill in the blank: The ideal systolic blood pressure range for controlled hypotension in ear surgery is _____ to _____ mm Hg.
True or false: Dexmedetomidine causes significant respiratory depression.
Fill in the blank: N₂O should be discontinued at least _____ minutes before closure of the middle ear if it is used.
True or false: Head-up tilt reduces surgical bleeding but increases the risk of air embolism.
Answers: 1. False (myringotomy is the exception; N₂O effects are not relevant when a pressure-venting tube is placed). 2. 80 to 90. 3. False (it provides sedation and analgesia without respiratory depression). 4. 15. 5. True.
Q: Explain the two-phase problem that N₂O creates during tympanoplasty.
A: Phase 1 (during surgery): while the middle ear cavity is open, N₂O causes no pressure buildup. Once the tympanic membrane graft is placed, continued N₂O can displace the graft by increasing pressure in the now-closed space. Phase 2 (on washout): when N₂O is discontinued, the remaining gas is rapidly absorbed from the middle ear, creating negative pressure that can dislodge the graft, cause serous otitis media, disarticulate the stapes, or impair hearing.
Q: A middle ear surgery case requires a bloodless field. List the physical techniques used to minimise bleeding.
A: Head-up tilt of 15 to 20 degrees, avoidance of venous obstruction and congestion through proper head positioning, normocapnia, and controlled hypotension.
Q: What are the advantages of dexmedetomidine as an adjunct in ENT surgery?
A: It provides sedation, analgesia, and a modest reduction in heart rate and blood pressure without causing respiratory depression. It can be used to lower blood pressure during general anaesthesia or as the primary sedative with supplementary low-dose propofol and midazolam for IV sedation.
Q: Why is a smooth, cough-free emergence particularly important after middle ear surgery?
A: Coughing and straining at emergence can dislodge an ossicular prosthesis or tympanic membrane graft, and can increase postoperative bleeding. Deep extubation may be considered to prevent this, provided there are no contraindications.
Q: Name five classes of pharmacological agents used for controlled hypotension in ENT surgery, with an example of each.
A: Inhalation anaesthetics (volatile agents), beta-adrenoceptor antagonists (labetalol, esmolol), alpha-2 adrenergic agonists (dexmedetomidine), opioids (remifentanil), and magnesium sulfate.
This material builds directly on the nerve preservation and neuromonitoring notes (Part 1), which explain why muscle relaxants and local anaesthetics are restricted. It connects forward to the myringotomy and tonsillectomy notes (Part 3), where the N₂O exception for myringotomy is explained and paediatric anaesthetic techniques are covered. The pharmacology of controlled hypotension overlaps with cardiovascular pharmacology in any CRNA curriculum, and PONV management connects to the broader topic of anti-emetic pharmacology and multimodal prophylaxis.
middle ear surgery, tympanoplasty, stapedectomy, ossiculoplasty, mastoidectomy, cholesteatoma, cochlear implantation, nitrous oxide, N₂O, closed air space, eustachian tube, tympanic membrane, ossicles, malleus, incus, stapes, oval window, stylomastoid foramen, bloodless field, controlled hypotension, MAP, mean arterial pressure, head-up tilt, air embolism, PONV, postoperative nausea, dexmedetomidine, alpha-2 agonist, remifentanil, labetalol, esmolol, magnesium sulfate, deep extubation, LMA, laryngeal mask airway, EMLA, CRNA, nurse anesthetist, otologic surgery, ENT anesthesia